background image

Paid Clinical Trials Portland

Discover 935 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & ResponsiveNew

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Portland OR, Seattle WA, Los Angeles CA, Iowa City IA,
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 26

Code: NCT03779854

Phase2, Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Portland OR, Vancouver, Clovis CA, Edmonton,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Portland OR, Vancouver WA, Vancouver, Kelowna,
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

for
Alzheimer Disease, Dementia
Location: Portland OR, Bellevue WA, Kelowna, Sherman Oaks CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 55 - 70+

Code: NCT06721156

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Portland OR, Chicago IL, Nashville TN, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

for
Primary Central Nervous System Lymphoma
Location: Portland OR, Seattle WA, Charlottesville VA, Hershey PA,
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06175000

Phase2, Recruiting
Active & Responsive

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

for
Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation,
Location: Portland OR, San Francisco CA, Los Angeles CA,
Sponsor: University of California, San Francisco

Sex: All

Age: 13 - 39

Code: NCT03749187

Phase1, Recruiting
Active & Responsive

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for
Prostate Carcinoma
Location: Portland OR, Seattle WA, Duarte CA, Chicago IL,
Sponsor: University of Washington

Sex: Male

Age: 40+

Code: NCT04472338

Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: Portland OR, Seattle WA, Boise ID, West Los Angeles CA,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting